Sign in with Google. Opens in new tab
bullish

Hugel Inc

Hugel Inc (145020 KS): Record High Performance in 2024; Continued Global Expansion to Drive Growth

Tina has highlighted this Insight as a Top Pick
465 Views14 Feb 2025 09:33
SUMMARY
  • Hugel Inc (145020 KS) reported record high sales, operating profit, and net profit in 2024, with the strong performance of botulinum toxin and fillers backed by the company’s global expansion.
  • Hugel aims to launch botulinum toxin in the U.S. within 1H25. The company aims for a 10% U.S. market share for aesthetic purposes within three years from the product release.
  • Hugel aims to expand its presence in more than 80 toxin markets (from 67 now), 70 dermal filler markets (current 52), and more than 10 cosmetics markets by 2028.
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
x